Research Starter Grants in Translational Medicine and Therapeutics

Funder: Phrma Foundation

Due Date: February 1,  2018

Budget: $100,000

“Translational medicine and therapeutics is a discipline focused on bridging experimental and computational research and discoveries to their application in clinical practice. To be successful, this requires working with clinicians to identify critical unmet clinical needs. Examples of research components include activities in molecular and cellular biology, pathophysiology, systems biology, bioinformatics, modeling and simulation, and other quantitative sciences to connect basic biological concepts and entities to directly address such unmet medical needs. Clinical observation becomes the basis for hypothesis generation to further basic research and to efficiently advance the product of basic research to patients.”

The goal of the PhRMA Foundation’s Translational Medicine and Therapeutics Program is to promote the development and use of experimental and computational methods in an integrative approach towards clinical needs in diagnosis, treatment and prevention. The Foundation believes that to be successful, this requires working with clinicians to identify critical unmet clinical needs.

This can involve enhanced understanding of human biological and disease processes but requires a strong translational component. This program will support the concepts of Translational Medicine and Therapeutics.

Translational Medicine and Therapeutics awards will advance training and support career development of scientists engaged in research that significantly addresses specific clinician-defined problems and integrates innovative technologies with advanced biological, chemical, and pharmacological sciences and engineering methodologies in areas such as:

Genetics (Molecular, Pharmaco-, Population, Medical)
Genomics (Functional, Structural, Toxico-, Pharmaco-, Comparative)
Systems (Biology and Pharmacology)
Pathways and Networks
Integrative Biology
Modeling and Simulation
Target Identification and Validation
Biomarker Discovery and Validation
Vaccine Development
Molecular Epidemiology
Imaging
Disease Modeling

Program Priorities

Leave a Reply